Last updated on December 2019

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation


Find a site near you

Start Over

UCLA Medical Center

Los Angeles, CA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

Ochsner Clinic Foundation

Jefferson, LA United States
  Connect »

John Theurer Cancer Center

Hackensack, NJ United States
  Connect »

New York Medical College

Valhalla, NY United States
  Connect »

Brody School of Medicine at ECU

Greenville, NC United States
  Connect »

Gabrail Cancer Center

Canton, OH United States
  Connect »

Oncology Hematology Care, Inc

Cincinnati, OH United States
  Connect »

Baylor Research Institute

Dallas, TX United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Flinders Medical Centre

Bedford Park, Australia
  Connect »

Hotel Dieu

Nantes, France
  Connect »

CHU Estaing

Clermont-Ferrand, France
  Connect »

National Cancer Center

Goyang, Korea, Republic of
  Connect »

Ajou University Hospital

Suwon-si, Korea, Republic of
  Connect »

SINACOR

Culiacan, Mexico
  Connect »

VU Medisch Centrum

Amsterdam, Netherlands
  Connect »

Regional Clinical Hospital

Krasnoyarsk, Russian Federation
  Connect »

City Clinical Hospital # 40

Moscow, Russian Federation
  Connect »

Republican Hospital n.a. V.A. Baranov

Petrozavodsk, Russian Federation
  Connect »

CHUS H. Clinico U. de Santiago

Santiago de Compostela, Spain
  Connect »

Hospital Son Llatzer

Palma de Mallorca, Spain
  Connect »

Hospital de Gran Canaria Doctor Negrin

Las Palmas de Gran Canaria, Spain
  Connect »

Maidstone Hospital

Maidstone, United Kingdom
  Connect »

Churchill Hospital

Oxford, United Kingdom
  Connect »

Pilgrim Hospital

Boston, United Kingdom
  Connect »

Flinders Medical Centre

Bedford park, Australia
  Connect »